Oxyrane derivative of α-lapachone is potent growth inhibitor of Trypanosoma cruzi epimastigote forms

Parasitology Research

Volumn 99, Issue 4, 2006, Pages 429-433

  Jorqueira, Alessandra ^a   Gouvêa, Robson M ^a   Ferreira, Vitor F ^a   Da Silva, Milton N ^a   De Souza, Maria C B V ^a   Zuma, Aline A ^a   Cavalcanti, Danielle F B ^a   Araújo, Humberto P ^b   Santos, Dilvani O ^b   Bourguignon, Saulo C ^a  

^a FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

^b Oswaldo Cruz Foundation   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

1,2 NAPHTHOQUINONE DERIVATIVE; 4 METHOXY 1,2 NAPHTHOQUINONE DERIVATIVE; ALPHA LAPACHONE DERIVATIVE; ANTIPROTOZOAL AGENT; BETA LAPACHONE DERIVATIVE; CRYSTAL VIOLET; NOR BETA LAPACHONE DERIVATIVE; OXYRANE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIPROTOZOAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG POTENCY; NONHUMAN; PRIORITY JOURNAL; TRYPANOSOMA CRUZI; VERO CELL;

ANIMALS; ANTIPROTOZOAL AGENTS; CELL SURVIVAL; CERCOPITHECUS AETHIOPS; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBROBLASTS; GROWTH INHIBITORS; NAPHTHOQUINONES; TRYPANOSOMA CRUZI; VERO CELLS;

TRYPANOSOMA CRUZI;

EID: 33748887224     PISSN: 09320113     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00436-006-0153-8     Document Type: Article

References (39)

1. Abreu FC, Ferraz PAL, Goulart MOF (2002) Some applications of electrochemistry in biomedical chemistry. Emphasis on the correlation of electrochemical and bioactive properties. J Braz Chem Soc 13:19-35
2. Almeida ER (1990) Antiinflammatory action of lapachol. J Ethnopharmacol 29:239-241
3. Babior BM (1997) Superoxide: a two-edged sword. Braz J Med Biol Res 30:141-155
4. Cazzulo JJ (2002) Proteinases of Trypanosoma Cruzi: Potential targets for the chemotherapy of chagas disease. Curr Top Med Chem 2:1257-1267
5. Chiang J, Averboukh L, Pardee AB, Chiang J, Averboukh L, Pardee AB (1993) β-Lapachone, a novel DNA topoisomerase I inhibitor with a mode of action different from camptothecin. J Biol Chem 268:22463-22475
6. De Moura KCG, Emery FS, Neves-Pinto C, Pinto MCFR, Dantas AP, Salomão K, de Castro SL, Pinto AV (2001) Trypanocidal activity of isolated naphthoquinones from Tabebuia and some heterocyclic derivatives: a review from an interdisciplinary study. J Braz Chem Soc 12:325-338
7. De Moura KCG, Salomão K, Menna-Barreto RFS, Emery FS, Pinto MCFR, Pinto AV, Castro SL (2004) Studies on the trypanocidal activity of semi-synthetic pyran[b-4,3]naphtho[1,2-d]imidazoles from β-lapachone. Eur J Med Chem 39:639-645
8. Di Chenna PH, Benedetti-Doctorovich V, Baggio RF, Garland MT, Burton G (2001) Preparation and cytotoxicity toward cancer cells of mono(arylimino) derivatives of β-lapachona. J Med Chem 44:2486-2489
9. dos Santos AF, Ferraz PAL, de Abreu FC, Chiari E, Goulart MDF, Sant'Ana AEG (2001) Molluscicidal and trypanocidal activities of lapachol derivatives. Planta Med 67:92-93
10. Dubin M, Fernandez Villamil SH, Stoppani AO (2001) Citotoxidad de la beta-Lapachona: Uma o-naftoquinona com posibles usos terapéuticos. Medicina 61:343-350
11. Du X, Hansell E, Engel JC, Caffrey CR, Cohen FE, McKerrow JH (2000) Aryl ureas represent a new class of anti-trypanosomal agents. Chem Biol 7:733-742
12. Ferreira VF, Pinto AV, Silva JS, Gilbert B (1992) Evaluation of some organic compounds on bloodsteam forms of Trypanosoma cruzi. Mem Inst Oswaldo Cruz 87:345-351
13. Finney DJ, Probit analysis, 3rd ed., (Cambridge University Press, London, 1971), pp 333-343
14. Franck X, Fournet A, Prina E, Mahieux R, Hocquemiller R, Figadère B (2004) Biological evaluation of substituted quinolines. Bioorg Med Chem Lett 14:3635-3638
15. Frydman B, Marton LJ, Sun SJ, Neder K, Witiak TD, Liu AA, Wang HM, Mao Y, Wu HY, Sanders MM, Liu LF (1997) Induction of DNA topoisomerase II-mediated DNA cleavage by β-lapachone and related naphthoquinones. Cancer Res 57:620-628
16. Gafner S, Wolfender J-L, Nianga M, Stoeckli-Evans H, Hostettmann K (1996) Antifungal and antibacterial naphthoquinones from Newbouldia laevis roots. Phytochemistry 42:1315-1320
17. Garzoni LR, Waghabi MC, Baptista MM, de Castro SL, Meirelles MNL, Britto CC, Docampo R, Oldfield E, Urbina JA (2004) Antiparasitic activity of risedronate in a murine model of acute Chagas' disease. Int J Antimicrob Agents 23:286-290
18. Hooker SC (1936) The Constitution of lapachol and its derivatives. Part V. The structure of Paternò's "Isolapachone". J Am Chem Soc 58:1190-1197
19. Krishnan P, Bastow KF (2000) Novel mechanisms of DNA topoisomerase II inhibition by pyranonaphthoquinone derivatives-eleutherin, α-lapachone, and β-lapachone. Biochem Pharmacol 60:1367-1379
20. Lacobuzio-Donahue CA, Shuja S, Cai J, Peng P, Murname MJ (1997) Elevations in cathepsin B protein content and enzyme activity occur independently of glycosylation during colorectal tumor progression. J Biol Chem 272:29190-29199
21. Margis R, Borojevic R (1989) Quantification of attached cells in tissue-culture plates and on microcarriers. Anal Biochem 181:209-211
22. Marr JJ, DoCampo R (1986) Chemotherapy for Chaga's disease: a perspective of current therapy and considerations for future research. Rev Infect Dis 8:884-903
23. Monks TJ, Hanzlik RP, Cohen GM, Ross D, Graham DG (1992) Quinone chemistry and toxicity. Toxicol Appl Pharmacol 112:2-16
24. Moreno SNJ, Carnieri EGS, DoCampo R (1994) Inhibition of trypanosoma-cruzi trypanothione reductase by crystal violet. Mol Biochem Parasitol 2:313-320
25. Neves-Pinto C, Malta VRS, Pinto MCFR, Santos RHA, de Castro SL, Pinto AV (2002) A trypanocidal phenazine derived from β-lapachone. J Med Chem 45:2112-2115
26. Pardee AB, Li YZ, Li CJ (2002) Cancer therapy with β-lapachone. Curr Cancer Drug Targets 2:227-242
27. Pinto AV, Pinto MCR, Gilbert B, Pellegrino J, Mello RT (1977) Schistosoma mansoni blockage of cercarial skin penetration by chemical agents: I. Naphthoquinones and derivatives. Trans R Soc Trop Med Hyg 71:133-135
28. Ravelo AG, Estévez-Braun A, Chávez-Orellana H, Pérez-Sacau E, Mesa-Siverio D (2004) Recent studies on natural products as anticancer agents. Curr Top Chem 4:241-265
29. Reinicke KE, Bey EA, Bentle MS, Pink JJ, Ingalls ST, Hoppel CL, Misico RI, Arzac GM, Burton G, Bornmann WG, Sutton D, Gao J, Boothman DA (2005) Development of beta-lapachone prodrugs for therapy against human cancer cells with elevated NAD(P)H:quinone oxidoreductase 1 levels. Clin Cancer Res 11:3055-3064
30. Roush WR, González FV, McKernow JH, Hansell E (1998) Design and synthesis of dipeptidyl α, β-epoxy ketones, potent irreversible inhibitors of the cysteine protease cruzain. Bioorg Med Chem Lett 8:2809-2912
31. Santos AF, Ferraz PAL, Pinto AV, Pinto MCFR, Goulart MOF, Sant'Ana AEG (2000) Molluscicidal activity of 2-hydroxy-3-alkyl-1,4-naphthoquinones and derivatives. Int J Parasitol 30:1199-1202
32. Santos EVM, Carneiro JWM, Ferreira VF (2004) Quantitative structure-activity relationship in aziridinyl-1,4-naphthoquinone antimalarials: study of theoretical correlations by the PM3 method. Bioorg Med Chem 12:87-93
33. Schinella GR, Tournier HA, Prieto JM, Ríos JL, Buschiazzo H, Zaidenberg A (2002) Inhibition of Trypanosoma cruzi growth by medical plant extracts. Fitoterapia 73:569-575
34. Scragg MA, Ferreira LR (1991) Evaluation of different staining procedures for the quantification of fibroblasts cultured in 96-well plates. Anal Biochem 198:80-85
35. Silva MN, Ferreira VF, de Souza MCBV (2003) Um panorama atual da química e da farmacologia de naftoquinonas, com ênfase na β-lapachona e derivados. Quím Nova 26:407-416
36. Subramanian S, Ferreira MMC, Trsic M (1998) Structure-activity relationship study of lapachol and some derivatives of 1,4-naphthoquinones against carcinosarcoma walker 256. Struct Chem 9:47-57
37. Teixeira MJ, Almeida YM, Viana JR, Holanda Filha JG, Rodrigues TP, Prata JRC Jr, Coelho ICB, Rao VS, Pompeu MML (2001) In vitro and in vivo leishmanicidal activity of 2-hydroxy-3-(3-methyl-2-butenyl)-1,4-naphthoquinone (lapachol). Phytother Res 15:44-48
38. Urbina JA (2002) Chemotherapy of Chagas' disease. Curr Pharm Des 8:287-295
39. Warren LG (1960) Metabolism of Schizotrypanum-cruzi, Chagas. I. Effect of culture age and substrate concentration on respiratory rate. J Parasitol 46:529-539